J Clin Oncol. 2009 Apr 20;27(12):2081-90. Epub 2009 Mar 2.

Malignant pleural mesothelioma.

Tsao AS, Wistuba I, Roth JA, Kindler HL.

Source

Department of Thoracic/Head and Neck Medical Oncology, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd, Unit 432, Houston, TX 77030, USA. astsao@mdanderson.org

Abstract

Malignant pleural mesothelioma (MPM) is a deadly disease that occurs in 2,000 to 3,000 people each year in the United States. Although MPM is an extremely difficult disease to treat, with the median overall survival ranging between 9 and 17 months regardless of stage, there has been significant progress over the last few years that has reshaped the clinical landscape. This article will provide a comprehensive discussion of the latest developments in the treatment of MPM. We will provide an update of the major clinical trials that impact mesothelioma treatment in the resectable and unresectable settings, discuss the impact of novel therapeutics, and provide perspective on where the clinical research in mesothelioma is moving. In addition, there are controversial issues, such as the role of extrapleural pneumonectomy, adjuvant radiotherapy, and use of intensity-modulated radiotherapy versus hemithoracic therapy that will also be addressed in this manuscript.

PMID:: 19255316; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms

Publication Types

Review

MeSH Terms

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Supplemental Content

Save items

Related citations in PubMed

Outcome for patients with malignant pleural mesothelioma referred for Trimodality therapy in Western Australia. [J Thorac Oncol. 2009]
Outcome for patients with malignant pleural mesothelioma referred for Trimodality therapy in Western Australia.
Hasani A, Alvarez JM, Wyatt JM, Bydder S, Millward M, Byrne M, Musk AW, Nowak AK. J Thorac Oncol. 2009 Aug; 4(8):1010-6.
Review Malignant pleural mesothelioma: a comprehensive review. [Cancer Control. 2006]
Review Malignant pleural mesothelioma: a comprehensive review.
Ismail-Khan R, Robinson LA, Williams CC Jr, Garrett CR, Bepler G, Simon GR. Cancer Control. 2006 Oct; 13(4):255-63.
Trimodality therapy with induction chemotherapy followed by extrapleural pneumonectomy and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma. [J Clin Oncol. 2009]
Trimodality therapy with induction chemotherapy followed by extrapleural pneumonectomy and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma.
de Perrot M, Feld R, Cho BC, Bezjak A, Anraku M, Burkes R, Roberts H, Tsao MS, Leighl N, Keshavjee S, et al. J Clin Oncol. 2009 Mar 20; 27(9):1413-8. Epub 2009 Feb 17.
Review Multidisciplinary treatment of malignant pleural mesothelioma. [Oncologist. 2007]
Review Multidisciplinary treatment of malignant pleural mesothelioma.
Ceresoli GL, Gridelli C, Santoro A. Oncologist. 2007 Jul; 12(7):850-63.
[Therapeutic strategies for resectable malignant pleural mesothelioma]. [Nihon Geka Gakkai Zasshi. 2009]
[Therapeutic strategies for resectable malignant pleural mesothelioma].
Hasegawa S. Nihon Geka Gakkai Zasshi. 2009 Nov; 110(6):338-42.

See reviews... See all...

Cited by 3 PubMed Central articles

Replication-competent retrovirus vector-mediated prodrug activator gene therapy in experimental models of human malignant mesothelioma. [Cancer Gene Ther. 2011]
Replication-competent retrovirus vector-mediated prodrug activator gene therapy in experimental models of human malignant mesothelioma.
Kawasaki Y, Tamamoto A, Takagi-Kimura M, Maeyama Y, Yamaoka N, Terada N, Okamura H, Kasahara N, Kubo S. Cancer Gene Ther. 2011 Aug; 18(8):571-8. Epub 2011 Jun 10.
HER1-targeted 86Y-panitumumab possesses superior targeting characteristics than 86Y-cetuximab for PET imaging of human malignant mesothelioma tumors xenografts. [PLoS One. 2011]
HER1-targeted 86Y-panitumumab possesses superior targeting characteristics than 86Y-cetuximab for PET imaging of human malignant mesothelioma tumors xenografts.
Nayak TK, Garmestani K, Milenic DE, Baidoo KE, Brechbiel MW. PLoS One. 2011 Mar 25; 6(3):e18198. Epub 2011 Mar 25.
Complete regression of human malignant mesothelioma xenografts following local injection of midkine promoter-driven oncolytic adenovirus. [J Gene Med. 2010]
Complete regression of human malignant mesothelioma xenografts following local injection of midkine promoter-driven oncolytic adenovirus.
Kubo S, Kawasaki Y, Yamaoka N, Tagawa M, Kasahara N, Terada N, Okamura H. J Gene Med. 2010 Aug; 12(8):681-92.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Malignant pleural mesothelioma.
Malignant pleural mesothelioma.
J Clin Oncol. 2009 Apr 20 ;27(12):2081-90. Epub 2009 Mar 2 .

PubMed
Second neoplasms in survivors of childhood cancer: findings from the Childhood C...
Second neoplasms in survivors of childhood cancer: findings from the Childhood Cancer Survivor Study cohort.
J Clin Oncol. 2009 May 10 ;27(14):2356-62. Epub 2009 Mar 2 .

PubMed
Trends in hospitalizations for AIDS-associated Pneumocystis jirovecii Pneumonia ...
Trends in hospitalizations for AIDS-associated Pneumocystis jirovecii Pneumonia in the United States (1986 to 2005).
Chest. 2009 Jul ;136(1):190-7. Epub 2009 Mar 2 .

PubMed
Surveillance of an infectious syphilis outbreak in south London, UK: a compariso...
Surveillance of an infectious syphilis outbreak in south London, UK: a comparison of reporting systems.
Int J STD AIDS. 2009 Mar ;20(3):196-9.

PubMed
Identifying opportunities for sexually transmitted infection prevention: analysi...
Identifying opportunities for sexually transmitted infection prevention: analysis of critical points in the care pathways of patients with gonorrhoea.
Int J STD AIDS. 2009 Mar ;20(3):170-5.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: